RESPIRATORY SYNCYTIAL VIRUSES

Clinical trials for RESPIRATORY SYNCYTIAL VIRUSES explained in plain language.

Never miss a new study

Get alerted when new RESPIRATORY SYNCYTIAL VIRUSES trials appear

Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1

Major trial tests new shot to shield seniors from dangerous RSV

Prevention Completed

This large, completed Phase 3 study tested whether a new vaccine could prevent serious lower respiratory tract disease caused by RSV in adults aged 60 and older. Over 25,000 participants were randomly assigned to receive either the experimental vaccine or a placebo shot. The main…

Matched conditions: RESPIRATORY SYNCYTIAL VIRUSES

Phase: PHASE3 • Sponsor: Janssen Vaccines & Prevention B.V. • Aim: Prevention

Last updated Mar 25, 2026 14:08 UTC

RESPIRATORY SYNCYTIAL VIRUSES

Get alerted when new RESPIRATORY SYNCYTIAL VIRUSES trials appear

Major trial tests new shot to shield seniors from dangerous RSV